Kelly Financial Services LLC Vertex Pharmaceuticals Inc Transaction History

Kelly Financial Services LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Jul 17, 2024	BUY	$273.83 - $305.53 $547 - $611	2 Added 2.78%	74 $21.4 Million
Q3 2021 Jul 17, 2024	SELL	$181.39 - $202.99 $2.62 Million - $2.93 Million	-14,445 Reduced 99.5%	72 $13.1 Million
Q2 2021 Jul 17, 2024	BUY	$187.49 - $221.1 $2.71 Million - $3.19 Million	14,445 Added 20062.5%	14,517 $72,000
Q3 2019 Jul 17, 2024	BUY	$166.23 - $187.09 $997 - $1,122	6 Added 9.09%	72 $12.2 Million
Q1 2019 Jul 17, 2024	BUY	$163.73 - $194.7 $10,806 - $12,850	66 New	66 $12.1 Million

1,723

222M

1.58M

1.36M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $116B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Kelly Financial Services LLC, based on Form 13F filings with the SEC.

Stay updated on Kelly Financial Services LLC with notifications on news.